SNY250516C65000
- 0.00
- 0.000.00%
Sanofi Newsroom
Sanofi Completes Opella Transaction, Shifts Focus to Biopharma
European Equities Traded in the US as American Depositary Receipts Drop Sharply in Wednesday Trading
Sanofi Closed Sale Of 50% Stake In Opella To CD&R For €10B
Press Release: Annual General Meeting of April 30, 2025
Press Release: Sanofi and CD&R Close Opella Transaction, Create Global Consumer Healthcare Leader
Regeneron Drops as Eylea Drives Q1 Miss
Sanofi, McLaren Racing Partner for Meningitis Awareness
Express News | Regeneron Pharmaceuticals Inc: Q1 2025 Dupixent(®) Global Net Sales (Recorded by Sanofi) Increased 19% to $3.67 Bln
Enterogermina Invites Physicist and Ig Nobel Winner to Develop a Toast That Defies Murphy's Law
Sanofi (SNYNF) Gets a Buy From UBS
Research Alert: CFRA Keeps Buy Opinion On Ads Of Sanofi
Goldman Sachs Reaffirms Their Hold Rating on Sanofi (SNYNF)
Sanofi Reports Strong Q1 2025 Performance
Sanofi and Sobi Extend Their Partnership With the World Federation of Hemophilia Humanitarian Aid Program
Sanofi Invests €15 Mln In Innate Pharma To Support Pipeline And Extend Cash Runway
Sanofi (SNY) Q1 2025 Earnings Call Transcript Summary
Sanofi Axes Development of Oral TNF Inhibitor as Monotherapy Following Phase II Fail
6-K: Strong Q1 Performance and 2025 Guidance Confirmed
French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit
Sanofi Proposes Annual Dividend of €3.92, a Hike of 4.26% From Prior Dividend